ish two hundred day moving average cross - a. in trading on friday shares of agilent technologies inc. (symbol: a) crossed above their 200 day moving average of $137.71 changing hands as high as $138.73 per share. agilent technologies inc.

ex-dividend reminder: agilent technologies bank of nova scotia and brixmor property group. looking at the universe of stocks we cover at dividend channel on 4/3/23 agilent technologies inc. (symbol: a) bank of nova scotia halifax (symbol: bn

why agilent technologies (a) is a top growth stock for the long-term. it doesnt matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. luckily zacks pr

agilent (a) boosts digital pathology reach with hamamatsu deal. agilent technologies a is leaving no stone unturned to bolster its diagnostics and genomics group (dgg) segment on the back of its strategic partnerships.this is evident f

agilent (a) boosts biopharma solutions offerings with e-msion. agilent technologies a is leaving no stone unturned to bolster its portfolio strength on the back of strategic acquisitions.this is evident from its latest announcement reg

agilent (a) to boost digital pathology reach with proscia deal. agilent technologies a signs a multi-year distribution agreement with proscia in a bid to deliver advanced digital diagnostic pathology solutions to the pathologists.per t

agilent in distribution agreement with proscia on digital diagnostic pathology system.

3 reasons growth investors will love agilent (a). investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the markets attention and produce exceptional returns. but finding a gre

agilent (a) loses -11.54% in 4 weeks heres why a trend reversal may be around the corner. agilent technologies (a) has been on a downward spiral lately with significant selling pressure. after declining 11.5% over the past four weeks t

agilents (a) q1 earnings & revenues beat estimates rise y/y. agilent technologies a reported first-quarter fiscal 2023 earnings of $1.37 per share beating the zacks consensus estimate by 4.6%. the bottom line increased 13% from the yea

agilent technologies is oversold. the dividendrank formula at dividend channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characte

looking into agilent technologiess recent short interest. ) short percent of float has fallen 5.0% since its last report. the company recently reported that it has

fluor (flr) unit wins agilents facility expansion contract. fluor corporation&rsquo.s flr advanced technologies &. life sciences business received a contract from agilent technologies inc. to expand the latter&rsquo.s oligonucleotid

agilent technologies selects turner to build $725 million pharmaceutical manufacturing plant in frederick colorado. facility will support agilent'.s mission to accelerate the production of oligonucleotide therapeutics that provide care to people f

heres how much $1000 invested in agilent technologies 15 years ago would be worth today. agilent technologies (nyse:) has outperformed the market over the past 15 years by 3.12% on an annualized basis producing an average annual return of 10.6%. currently

agilent inks deal with quest diagnostics to offer ctdx first liquid biopsy test across us. (rttnews) - agilent technologies inc. (a) announced monday an agreement with quest diagnostics (dgx) a diagnostic information services company to enable p

$100 invested in this stock 5 years ago would be worth $200 today. agilent technologies (nyse:) has outperformed the market over the past 5 years by 9.09% on an annualized basis producing an average annual return of 16.16%. currently agilent technologies

agilent technologies inc. (a) ceo michael mcmullen presents at 41st annual j.p. morgan healthcare conference (transcript).

agilent technologies inc. shares near 52-week high - market mover. agilent technologies inc. (a) shares closed today at 1.2% below its 52 week high of $160.03 giving the company a market cap of $45b. the stock is currently up 3.7% year-to-date u

agilent technologies to repurchase up to $2 bln of stock. (rttnews) - agilent technologies inc. (a) said that its board has approved a new share repurchase program. the 2023 program authorizes the purchase of up to $2 billion of the companys

agilent: flexing its build and buy strategy but wait for a pullback.

agilent technologies to invest $725 mln to double capacity for oligos. (rttnews) - agilent technologies inc. (a) monday announced that it will invest $725 million to double the manufacturing capacity of therapeutic nucleic acids or oligos. the i

agilent akoya partner to drive multiplex tissue assay development for biopharma applications. (rttnews) - agilent technologies inc. (a) said that it has partnered with akoya biosciences inc. (akya) to develop multiplex-immunohistochemistry diagn

agilent (a) to expand portfolio with avida biomed acquisition. agilent technologies a made an announcement to take over an early-stage life sciences company avida biomed.

earnings growth & price strength make agilent technologies (a) a stock to watch. here at zacks we offer our members many different opportunities to take full advantage of the stock market as well as how to invest in ways that lead to l

agilent acquires avida biomed boosting next-generation sequencing for cancer research.

agilent to acquire avida for cancer research.